Full-Time

Associate Managed Care Liaison Director

Confirmed live in the last 24 hours

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$206.4k - $298.9kAnnually

+ Annual Bonus (30% of base salary) + Equity-based long term incentive program

Senior, Expert

Tennessee, USA + 1 more

More locations: Illinois, USA

Must be located near a major airport and willing to travel up to 50% of the time.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • PhD, PharmD or equivalent in a health science field and 7+ years of field Medical Affairs experience, including 2+ year of previous MSL experience addressing scientific and clinical issues of policy in a Managed care, Market Access role and/or relevant transferable experience (clinical practice, academic research, regulatory/scientific).
  • Experience with health plan drug utilization decision-making (Pharmacy and Therapeutics Committee, DUR, Guideline Panels, ICER).
  • Experience in conducting and communicating the results of health outcomes research.
  • OR PhD, PharmD or equivalent in a health science field and 1+ years of field Medical Affairs Experience and 3+ years MCO experience.
  • Emerging as an internal thought leader with technical and/or business expertise.
  • Applies in-depth knowledge of own area of expertise to solve problems.
  • Applies expertise to manage critical projects and/or relationships.
  • Integrates analysis of business objectives and strategic direction to resolve problems and recommend solutions.
  • Has input into short-term strategy and may be involved in long-term strategy on a functional level.
  • Strong communications, problem-solving, analytical thinking, influencing skills.
  • Expertise in health economic principles and clinical trials.
  • Proven experience conducting and communicating the results of clinical trials, RWE and health economics and outcomes research.
  • Strong understanding of regulations and current FDA guidance covering interactions of industry and managed care organizations.
  • Strong-track record of fostering relationships and demonstrated ability to identify national, regional, and local KOLs/PBDMs.
  • Uses extensive knowledge of FDA guidance to make informed decisions as an individual contributor.
  • Proven ability to network and partner with external stakeholders, specifically managed care organizations.
  • Extensive knowledge of all the clinical and scientific data for our product(s), as well as a deep understanding of managed markets.
Responsibilities
  • Present Neurocrine's groundbreaking therapies to key formulary and access decision-makers.
  • Champion the value proposition of innovative products to Medical Access influencers and stakeholders across Managed Markets, Payers, Government Programs, and Managed Care Organizations.
  • Forge and sustain influential relationships with managed care thought leaders, ensuring optimal patient access to treatments.
  • Engage in health economics and outcomes data, driving collaborative opportunities for current treatments and pipeline products.
  • Provide scientific guidance for Health Economics (HEOR) to internal stakeholders and consultants, supporting advisory board activities as needed.
  • Strengthen the Directors of Field Medical Affairs teams, offering expert training, development of compelling testimonies, and other critical resources.
  • Educate internal teams on the roles and value of the MCL team, and elevate the expertise of other FMA teams through specialized training sessions.
Desired Qualifications
  • Ability to network and partner with external stakeholders, specifically managed care organizations.
  • Strong understanding of managed markets.
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

1992

Simplify Jobs

Simplify's Take

What believers are saying

  • CRENESSITY's FDA approval marks a significant advancement in CAH treatment.
  • Collaboration with Nxera Pharma strengthens Neurocrine's position in neuropsychiatric therapeutics.
  • Participation in major healthcare conferences boosts Neurocrine's visibility and investor relations.

What critics are saying

  • Increased competition in muscarinic agonist market may impact Neurocrine's market share.
  • Reliance on PANTHERx Rare for distribution poses potential partnership risks.
  • High cost of CRENESSITY could limit patient accessibility and market penetration.

What makes Neurocrine Biosciences unique

  • CRENESSITY is the first non-steroidal treatment for classic congenital adrenal hyperplasia.
  • Neurocrine's muscarinic agonist portfolio targets innovative treatments for neuropsychiatric disorders.
  • Partnership with Pantherx® Rare enhances patient access to rare disease treatments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Parental Leave

Health Insurance

Dental Insurance

Vision Insurance

Paid Holidays